Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 137 | 108 | 4 | 1 |
| Operating Income | -137 | -108 | -4 | -1 |
| Other Income | 1 | 1 | 0 | 0 |
| Pre-tax Income | -136 | -108 | -4 | -1 |
| Net Income Continuous | -136 | -108 | -4 | -1 |
| Net Income | $-136 | $-108 | $-4 | $-1 |
| EPS Basic Total Ops | -0.53 | -0.99 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.12 | -0.08 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.53 | -0.99 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.12 | -0.08 | 0.00 | 0.00 |
| EBITDA(a) | $-137 | $-108 | $-4 | $-1 |